| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4240664 | Journal of Vascular and Interventional Radiology | 2011 | 7 Pages |
Abstract
The present findings confirm the effectiveness of RE plus systemic chemotherapy for metastatic CRC. Patients with liver-confined disease derived the greatest benefit, with median survival times beyond 36 months. Larger datasets from ongoing phase III trials are needed to further define the safety and efficacy of RE in the first-line setting.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Suzanne MBBS, Thean H. MBBS, Desmond MBBS, Richard MBBS, BMedSc, Meir MBBS, Peter MD,